Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
59 hedge funds and large institutions have $103M invested in Alpine Immune Sciences Inc in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 15 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 15
6% less funds holding
Funds holding: 63 → 59 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
40% less capital invested
Capital invested by funds: $173M → $103M (-$69.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$10.2M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.01M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$646K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$539K |
| 5 |
Axa
Paris,
France
|
+$463K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.35M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$3M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.27M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.1M |
| 5 |
GL
GLG LLC
New York
|
-$1.44M |
ALPN Hedge Fund Activity: Q4 2015 in Review
59 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q4 2015, worth a combined $103M — down 40% from $173M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ALPN and 11 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 18 added.
The largest buyer was BVF Inc, opening a new position worth an estimated $10.2M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $3.35M sold.
- 59 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q4 2015, down from 63 in Q3 2015.
- Funds reported $103M of Alpine Immune Sciences Inc stock for Q4 2015, down 40% quarter-over-quarter.
- 11 funds opened new Alpine Immune Sciences Inc positions in Q4 2015 and 15 closed out, a net change of -4 holders.
- The largest Alpine Immune Sciences Inc buyer in Q4 2015 was BVF Inc, an estimated $10.2M added.
- The largest Alpine Immune Sciences Inc seller in Q4 2015 was Lord, Abbett & Co, an estimated $3.35M sold.
Based on aggregated 13F filings for Q4 2015.